Nebulization of a bovine surfactant in cystic fibrosis: a pilot study

Cystic fibrosis (CF) is a lethal disorder which results in excessive airway secretions and in chronic inflammation of the airways. In vitro and in vivo studies have shown that a lack of surfactant results in the closure of the small airways. In this pilot study, we aimed to determine whether surfactant administered by aerosol might improve lung function on a short-term basis in patients with CF. In a randomized, crossover double-blind pilot study, 120 mg of a lipid-extracted bovine surfactant (Alveofact) or placebo was aerosolized to five young adult patients with CF over a period of 30 min for five consecutive days. The sample size had the power of 90% to detect an increase in forced expiratory volume in one second (FEV1) of 15% (p < 0.05). Jet nebulization of surfactant produced particles of which more than 75% were the respirable range (< 5 microns). The inhalations were well tolerated. No changes in serum antibody titres against the surfactant proteins-B and -C (SP-B/SP-C) were observed. No differences in FEV1 and forced vital capacity were found before, and 30 or 90 min after, the inhalation. This pilot study shows no acute or short-term benefits of surfactant inhalation in young adults with cystic fibrosis. However, a beneficial effect of exogenous surfactant cannot be excluded before other reasons for a lack of effect, such as insufficient quantity delivered, inhomogeneous distribution or inhibition of the surfactant in the lungs, have been completely ruled out.

This article has been cited by other articles:

				K. C. Meyer, A. Sharma, R. Brown, M. Weatherly, F. R. Moya, J. Lewandoski, and J. J. Zimmerman Function and Composition of Pulmonary Surfactant and Surfactant-Derived Fatty Acid Profiles Are Altered in Young Adults With Cystic Fibrosis Chest, July 1, 2000; 118(1): 164 - 174. [Abstract] [Full Text] [PDF]

				R. Banerjee and R. R. Puniyani Exogenous Surfactant Therapy and Mucus Rheology in Chronic Obstructive Airway Diseases J Biomater Appl, January 1, 2000; 14(3): 243 - 272. [Abstract] [PDF]

				A. D. Postle, A. Mander, K. B. M. Reid, J.-Y. Wang, S. M. Wright, M. Moustaki, and J. O. Warner Deficient Hydrophilic Lung Surfactant Proteins A and D with Normal Surfactant Phospholipid Molecular Species in Cystic Fibrosis Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 90 - 98. [Abstract] [Full Text]